NuScale Power's 29% First-Half Drop Reflects Commercialization Stagnation and Dilution Risks

What happened

NuScale Power stock fell 29% in the first half of 2026 as mounting losses and a years-to-commercialization outlook dampened sentiment. The decline reflects investor disappointment over the lack of binding power purchase agreements or module delivery contracts, especially regarding the ENTRA1 partnership. The company's Q1 2026 revenue was just $0.6 million against operating cash burn of $315 million, with the cash drain largely due to a $260 million payment to ENTRA1 under the milestone agreement. Meanwhile, NuScale continues to dilute shareholders through a $1.0 billion at-the-market program, having sold 25.5 million shares in Q1 and early Q2 for $251 million. The stock's drop aligns with filings that show no verifiable progress toward Milestone 2—a binding PPA that would trigger the next ENTRA1 milestone payment.

Implication

The 29% decline validates the thesis that SMR equity prices a near-term commercialization step that SEC filings do not support. Without a binding PPA between ENTRA1 and TVA, NuScale's largest potential market remains a non-binding framework. The company's cash burn, primarily funding partner milestones without guaranteed revenue capture, will continue to erode per-share value if equity issuance persists. The next 6-9 months are critical: if Milestone 2 (PMA contribution 2) is not triggered by year-end, the stock could test the bear case value of $7.00. Investors should only reconsider if a filed 8-K confirms a binding PPA and a simultaneous NuScale OEM/supply contract, which would convert the narrative from speculative to bankable.

Thesis delta

The thesis remains intact: the stock's decline reinforces our 'Potential Sell' rating. No new information changes the fundamental gap between market pricing and filing reality. The key risk of dilution and non-binding milestones remains the dominant driver.